Loss of the eukaryotic initiation factor 3f in pancreatic cancer

被引:53
作者
Doldan, Adriana [1 ]
Chandramouli, Anupama [1 ]
Shanas, Renee [1 ]
Bhattacharyya, Achyut [1 ]
Cunningham, John T. [2 ]
Nelson, Mark A. [1 ]
Shi, Jiaqi [1 ]
机构
[1] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Med, Tucson, AZ 85724 USA
关键词
eukaryotic initiation factor 3f; loss of heterozygosity; apoptosis; pancreatic cancer;
D O I
10.1002/mc.20379
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant regulation of the translation initiation is known to contribute to tumorigenesis. eIF3 plays an important role in translation initiation. eIF3f is the p47 subunit of the eIF3 complex whose function in cancer is not clear. Initial studies from our group indicated that eIF3f expression is decreased in pancreatic cancer. Overexpression of eIF3f induces apoptosis in pancreatic cancer cells. The eIF3f gene is located at chromosome band region 11 p15.4. Loss of 11p15.4 is a common event in many tumors including pancreatic cancer. In order to investigate the molecular mechanism of the decreased expression of eIF3f in pancreatic cancer, we performed loss of heterozygosity (LOH) analysis in 32 pancreatic cancer specimens using three microsatellite markers encompassing the eIF3f gene. We showed that the prevalence of LOH ranged from 71 % to 93%. We also performed eIF3f gene copy number analysis using quantitative real time PCR to further confirm the specific allelic loss of eIF3f gene in pancreatic cancer. We demonstrated a statistically significant decrease of eIF3f gene copy number in pancreatic tumors compared with normal tissues with a tumor/normal ratio of 0.24. Furthermore, RNA in situ hybridization and tissue microarray immunohistochemistry analysis demonstrated that eIF3f expression is significantly decreased in human pancreatic adenocarcinoma tissues compared to normal pancreatic tissues. These data provides new insight into the understanding of the molecular pathogenesis of eIF3f during pancreatic tumorigenesis. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 44 条
  • [1] Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma -: Frequent allelic loss on chromosome 11p and alterations in the APC/β-catenin pathway
    Abraham, SC
    Wu, TT
    Hruban, RH
    Lee, JH
    Yeo, CJ
    Conlon, K
    Brennan, M
    Cameron, JL
    Klimstra, DS
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03) : 953 - 962
  • [2] Current approaches to novel therapeutics in pancreatic cancer
    Akerele, CE
    Rybalova, I
    Kaufman, HL
    Mani, S
    [J]. INVESTIGATIONAL NEW DRUGS, 2003, 21 (01) : 113 - 129
  • [3] Selected features of nonendocrine pancreatic cancer
    Anderson, KM
    Harris, JE
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 226 (06) : 521 - 537
  • [4] Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells
    Avdulov, S
    Li, S
    Michalek, V
    Burrichter, D
    Peterson, M
    Perlman, DM
    Manivel, JC
    Sonenberg, N
    Yee, D
    Bitterman, PB
    Polunovsky, VA
    [J]. CANCER CELL, 2004, 5 (06) : 553 - 563
  • [5] Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR
    Coupry, I
    Monnet, L
    Attia, AAM
    Taine, L
    Lacombe, D
    Arveiler, B
    [J]. HUMAN MUTATION, 2004, 23 (03) : 278 - 284
  • [6] The genetics of pancreatic cancer
    Cowgill, SM
    Muscarella, P
    [J]. AMERICAN JOURNAL OF SURGERY, 2003, 186 (03) : 279 - 286
  • [7] Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease
    di Mola, FF
    Friess, H
    Scheuren, A
    Di Sebastiano, P
    Graber, H
    Egger, B
    Zimmermann, A
    Korc, M
    Büchler, MW
    [J]. ANNALS OF SURGERY, 1999, 229 (01) : 67 - 75
  • [8] ABROGATION OF TRANSLATION INITIATION-FACTOR EIF-2 PHOSPHORYLATION CAUSES MALIGNANT TRANSFORMATION OF NIH 3T3 CELLS
    DONZE, O
    JAGUS, R
    KOROMILAS, AE
    HERSHEY, JWB
    SONENBERG, N
    [J]. EMBO JOURNAL, 1995, 14 (15) : 3828 - 3834
  • [9] Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival
    Dundas, SR
    Lawrie, LC
    Rooney, PH
    Murray, GI
    [J]. JOURNAL OF PATHOLOGY, 2005, 205 (01) : 74 - 81
  • [10] ECCLES DM, 1992, DIS MARKERS, V10, P95